Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Blood Plasma Derivatives Market Grown from 2024 to 2025?

The market size for blood plasma derivatives has seen a robust growth in the past years. The market size is projected to increase from $51.81 billion in 2024 to $56.24 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the historic period include an uptick in cases of hemophilia and bleeding disorders, an aging population, raised awareness and diagnosis, an increase in surgical procedures, and blood transfusion services globally.

What Growth Rate Is Anticipated for the Blood Plasma Derivatives Market in the Coming Years?

The market for blood plasma derivatives is predicted to experience significant expansion in the coming years, potentially reaching a value of $80.42 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.4%. This robust growth projected for the forecast period can be ascribed to the introduction of therapies for rare diseases, the rise in chronic diseases, increased healthcare spending, the adoption of patient-focused treatment methodologies, and the developing healthcare infrastructure. Notable trends during the forecast period encompass advancements in technology pertaining to fractionation, patient-focused strategies, collaborations and partnerships, increasing usage in neurology, and technological breakthroughs in plasma fractionation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

Who Are the Leading Companies in the Blood Plasma Derivatives Market?

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

What Are the Key Drivers of the Blood Plasma Derivatives Market?

The proliferation of disorders related to immunodeficiency is predicted to fuel the expansion of the blood plasma derivatives market. Illnesses that either fully or partly impair the body’s immune system fall under immunodeficiency disorders. Blood plasma derivatives are widely applied in the treatment of various medical issues, including immunodeficiency disorders. Comprising over 100 separate proteins and salts, plasma is a solution in which immunoglobulins are extensively used to treat primary immunodeficiencies. Immunodeficiency can be caused by macro and micronutrient deficiencies resulting from poor or inadequate nutrition. For example, research published by Allergy, Asthma & Clinical Immunology in March 2022, revealed that Common Variable Immunodeficiency (CVID) was the most frequent condition, affecting 16.6% of US residents, 12.9% of individuals at an international level and 13.9% globally. Consequently, the escalating incidence rate of immunodeficiency disorders is propelling the growth of the blood plasma derivatives market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

What Are the Key Market Segments in the Blood Plasma Derivatives Industry?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

What Are the Latest Trends in the Blood Plasma Derivatives Market?

Leading players in the blood plasma derivatives sector are strategizing partnerships to secure a competitive advantage in the market. Through these collaborations, patients requiring plasma-derived medications will have a consistent and trustworthy source, fulfilling the growing demand for immunoglobulins not only in France but worldwide. For example, in January 2022, an Italian biopharmaceutical corporation, Kedrion S.p.A., known for its work in creating, manufacturing, and distributing plasma-derived therapies, joined forces with LPB, a UK-based pharmaceutical firm expert in biological medicinal products. Kedrion aims to use LFB plasma, obtained from Etablissement Français du Sang (EFS) in France, for producing immunoglobulins in Hungary. The existing immunoglobulin supplies, destined for nation-wise hospital distribution under the watchful eyes of French health authorities, will receive a boost from these additional imports from LFB in France.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

What Are the Key Regional Markets in the Blood Plasma Derivatives Industry?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

This Report Delivers Insight On:

1. How big is the blood plasma derivatives market, and how is it changing globally?

2. Who are the major companies in the blood plasma derivatives market, and how are they performing?

3. What are the key opportunities and risks in the blood plasma derivatives market right now?

4. Which products or customer segments are growing the most in the blood plasma derivatives market?

5. What factors are helping or slowing down the growth of the blood plasma derivatives market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model